Market revenue in 2023 | USD 171.9 million |
Market revenue in 2030 | USD 162.1 million |
Growth rate | -0.8% (CAGR from 2023 to 2030) |
Largest segment | Quantitative |
Fastest growing segment | Digital |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quantitative, Digital, End-point |
Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 87.61% in 2023. Horizon Databook has segmented the South Korea real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing number of strategic initiatives by the government to address the challenges in diagnosing infectious diseases in the country is expected to drive the market. This agreement is expected to strengthen the relations between South Korea and WHO, improving global healthcare.
In addition, local manufacturers’ launch of new PCR instruments is expected to boost the sales of PCR kits in the market. For instance, in February 2022, Seegene, Inc. received a CE-marking for its Allplex SARS-CoV-2 fast MDx Assay.
Moreover, the growing incidence of infectious diseases, such as scarlet fever, measles, mumps, hepatitis A, and pertussis, is expected to drive the market. Furthermore, the rising geriatric population is likely to contribute significantly to market expansion in South Korea.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This country databook contains high-level insights into South Korea real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account